Viewing StudyNCT05512780



Ignite Creation Date: 2024-05-06 @ 6:01 PM
Last Modification Date: 2024-10-26 @ 2:40 PM
Study NCT ID: NCT05512780
Status: UNKNOWN
Last Update Posted: 2022-08-23
First Post: 2022-08-22

Brief Title: Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positiveHER2-negative Breast Cancer
Sponsor: Hebei Medical University Fourth Hospital
Organization: Hebei Medical University Fourth Hospital

Conditions & Keywords Data

Conditions:
Name
Solid Tumor
Keywords: